Concepedia

Gerald S. Falchook

GS

212

Publications

25.1K

Citations

66

H-Index

2003

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Sarah Cannon

HealthONE

University of California San Diego

Tennessee Oncology

Gerald S. Falchook is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and cancer research.

ORCID

Top concepts

Publications per year

2003–2024

212

Publications

212

Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations

Keith T. Flaherty, J. Infante, Adil Daud et al. · New England Journal of Medicine · 2012 · 2.8K citations · Full text

The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity

Jude Canon, Karen Rex, Anne Y. Saiki et al. · Nature · 2019 · 2.2K citations

, , +5

Sotorasib for Lung Cancers with <i>KRAS</i> p.G12C Mutation

Ferdinandos Skoulidis, Bob T. Li, Grace K. Dy et al. · New England Journal of Medicine · 2021 · 1.6K citations · Full text

KRAS <sup>G12C</sup> Inhibition with Sotorasib in Advanced Solid Tumors

David S. Hong, Marwan Fakih, John H. Strickler et al. · New England Journal of Medicine · 2020 · 1.6K citations · Full text

Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial

Gerald S. Falchook, Georgina V. Long, Razelle Kurzrock et al. · The Lancet · 2012 · 928 citations · Full text

, , +7

Rows per page

1–5 of 212